Key Highlights

  • Xanadu shares are trading down 7.68% at $2.59 versus a prior close of $2.80.
  • Third quarter Revenue was $1.3 million, down from $1.5 million in the second quarter.
  • The net loss was $32.2 million, versus $42.1 million in the second quarter.
  • Cash ended at $286.5 million, with no draw on the synthetic at-the-market program.
  • The roadmap targets up to 200 logical qubits in 2029.

Xanadu Quantum Technologies (NASDAQ:XNDU) is trading down 7.68% at $2.59, a Penny Stock sliding after a third quarter update that showed higher spending and tiny revenue. Management said revenue is not a material driver near term.

Losses and Spending

Revenue was $1.3 million versus $1.5 million in the second quarter and $1 million a year ago. The net loss was $32.2 million versus $42.1 million in the second quarter, while the adjusted EBITDA loss widened to $26.3 million from $21.3 million. Research and Development was $25.6 million, up $5.9 million from the prior quarter. Headcount rose to 361 from 306.

Costs and Capital spending are expected to grow in the fourth quarter on GlobalFoundries spending, hiring and equipment. No formal guidance was given.

Balance Sheet and Funding

Cash ended at $286.5 million, down $26.3 million from the second quarter. The company did not draw on its synthetic at-the-market program, which still has about $232.8 million available.

Funding includes a definitive agreement for about $140 million from the Government of Canada, received over time as qualifying research costs are incurred. It also has provisional approval for up to $10 million under DARPA's Quantum Benchmarking Initiative.

Roadmap Targets

The hardware roadmap targets up to 200 logical qubits in 2029 at error rates as low as 10 to the minus 8, up to 500 in 2030 and 1,000 or more by 2031. The company aims for a commercially viable quantum computer in 2029 to 2030 and expects to begin using its Inception Facility early next year.

Loss reduction is the key engineering challenge. Xanadu posted a record 7 millidB electro-optic switch, down from about 20 millidB last year, and the homodyne detector improved twofold. The fiber delay line improved more than threefold.

Analyst View

Both analysts covering the stock are bullish, with an average target of $18.50 and a range of $13 to $24. The stock trades in a 52-week range of $2.34 to $42.44 since its March listing.

Cash Runway and Milestones Decide the Next Move

With spending rising and revenue marginal, the stock trades on engineering milestones and funding. Investors will watch fourth quarter costs against the third quarter run rate, the pace of Government of Canada funding receipts and whether the Inception facility starts on time.

Further loss reductions in photonic components are the near-term technical markers on the way to the 2029 target.